|
Cephalon isn't asleep at the wheel. The company sells PROVIGIL, a treatment for the sleep disorder narcolepsy, in the US and select countries around the world. The company's other top sellers are cancer pain medications ACTIQ and FENTORA, epilepsy treatment GABITRIL (licensed from Abbott Labs and Novo Nordisk), and cancer drug TREANDA. It sells seven products in the US and has more than a dozen approved drugs on the market in Europe. Cephalon's drug research and development activities focus on central nervous system disorders, cancer, and pain.
|
| | | Contact Information | |
Address: |
41 Moores Rd.
Frazer, PA 19355
| | Phone: | 610-344-0200 | | Fax: | 610-738-6590 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 1974.60 M | | Revenue Growth (1 yr): | 11.40% | | Employees (2008): | 2,780 | | Employee Growth (1 yr): | (-0.60%) |
|
|
Key People
| | • |
Chairman and CEO:
Frank Baldino Jr.
| | • |
EVP and CFO:
J. Kevin Buchi
| | • |
EVP Worldwide Technical Operations:
Peter E. Grebow
|
|
|
